VERA BRADLEY INC (VRA)
US92335C1062 - Common Stock
Overall VRA gets a fundamental rating of 3 out of 10. We evaluated VRA against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. VRA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. VRA does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
VRA had negative earnings in the past year.
In the past year VRA has reported a negative cash flow from operations.
VRA had positive earnings in 4 of the past 5 years.
VRA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
VRA's Return On Assets of -4.76% is on the low side compared to the rest of the industry. VRA is outperformed by 71.43% of its industry peers.
With a Return On Equity value of -7.58%, VRA is not doing good in the industry: 65.31% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.76% | ||
| ROE | -7.58% | ||
| ROIC | N/A |
ROA(3y)-3.09%
ROA(5y)-0.92%
ROE(3y)-5.1%
ROE(5y)-1.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of VRA has declined.
In the last couple of years the Operating Margin of VRA has declined.
VRA's Gross Margin of 52.19% is fine compared to the rest of the industry. VRA outperforms 61.22% of its industry peers.
In the last couple of years the Gross Margin of VRA has remained more or less at the same level.
VRA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 52.19% |
OM growth 3Y-16.78%
OM growth 5Y-9.23%
PM growth 3Y-3.59%
PM growth 5Y-19.74%
GM growth 3Y-1.33%
GM growth 5Y-1.02%
2. Health
2.1 Basic Checks
VRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VRA has about the same amount of shares outstanding.
The number of shares outstanding for VRA has been reduced compared to 5 years ago.
VRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 2.93 indicates that VRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
VRA's Altman-Z score of 2.93 is in line compared to the rest of the industry. VRA outperforms 55.10% of its industry peers.
There is no outstanding debt for VRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.93 |
ROIC/WACCN/A
WACC9.43%
2.3 Liquidity
VRA has a Current Ratio of 3.09. This indicates that VRA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.09, VRA is in the better half of the industry, outperforming 79.59% of the companies in the same industry.
VRA has a Quick Ratio of 3.09. This is a bad value and indicates that VRA is not financially healthy enough and could expect problems in meeting its short term obligations.
VRA's Quick ratio of 0.89 is on the low side compared to the rest of the industry. VRA is outperformed by 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.09 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
The earnings per share for VRA have decreased strongly by -140.68% in the last year.
The Earnings Per Share has been decreasing by -1.76% on average over the past years.
Looking at the last year, VRA shows a very negative growth in Revenue. The Revenue has decreased by -16.39% in the last year.
VRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.50% yearly.
EPS 1Y (TTM)-140.68%
EPS 3Y-4.5%
EPS 5Y-1.76%
EPS Q2Q%-242.11%
Revenue 1Y (TTM)-16.39%
Revenue growth 3Y0.18%
Revenue growth 5Y2.5%
Sales Q2Q%-29.92%
3.2 Future
The Earnings Per Share is expected to decrease by -30.27% on average over the next years. This is quite bad
The Revenue is expected to decrease by -2.79% on average over the next years.
EPS Next Y-119.64%
EPS Next 2Y-30.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-19.77%
Revenue Next 2Y-8.26%
Revenue Next 3Y-2.79%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
VRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
VRA is valuated correctly with a Price/Forward Earnings ratio of 14.17.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VRA indicates a somewhat cheap valuation: VRA is cheaper than 71.43% of the companies listed in the same industry.
VRA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.53.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.17 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as VRA's earnings are expected to decrease with -30.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-30.27%
EPS Next 3YN/A
5. Dividend
5.1 Amount
VRA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
VERA BRADLEY INC
NASDAQ:VRA (1/14/2025, 8:12:12 PM)
After market: 3.72 0 (0%)3.72
+0.09 (+2.48%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners68.67%
Inst Owner Change0.01%
Ins Owners8.33%
Ins Owner Change-0.72%
Market Cap103.16M
Analysts80
Price Target6.38 (71.51%)
Short Float %12.78%
Short Ratio8.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-283.77%
Min EPS beat(2)-545.54%
Max EPS beat(2)-21.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-14.12%
Min Revenue beat(2)-19.17%
Max Revenue beat(2)-9.07%
Revenue beat(4)0
Avg Revenue beat(4)-10.74%
Min Revenue beat(4)-19.17%
Max Revenue beat(4)-3.02%
Revenue beat(8)1
Avg Revenue beat(8)-6.74%
Revenue beat(12)2
Avg Revenue beat(12)-5.79%
Revenue beat(16)3
Avg Revenue beat(16)-4.7%
PT rev (1m)-3.85%
PT rev (3m)-3.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-48%
EPS NY rev (1m)-205%
EPS NY rev (3m)-118.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.08%
Revenue NY rev (1m)-7.34%
Revenue NY rev (3m)-7.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.17 | ||
| P/S | 0.25 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.46 | ||
| P/tB | 0.47 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.24
EYN/A
EPS(NY)0.26
Fwd EY7.06%
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS14.61
BVpS8.12
TBVpS7.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.76% | ||
| ROE | -7.58% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 52.19% | ||
| FCFM | N/A |
ROA(3y)-3.09%
ROA(5y)-0.92%
ROE(3y)-5.1%
ROE(5y)-1.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-16.78%
OM growth 5Y-9.23%
PM growth 3Y-3.59%
PM growth 5Y-19.74%
GM growth 3Y-1.33%
GM growth 5Y-1.02%
F-Score5
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 70.93% | ||
| Cap/Sales | 1.79% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.09 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 2.93 |
F-Score5
WACC9.43%
ROIC/WACCN/A
Cap/Depr(3y)48.74%
Cap/Depr(5y)45.48%
Cap/Sales(3y)1.15%
Cap/Sales(5y)1.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-140.68%
EPS 3Y-4.5%
EPS 5Y-1.76%
EPS Q2Q%-242.11%
EPS Next Y-119.64%
EPS Next 2Y-30.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.39%
Revenue growth 3Y0.18%
Revenue growth 5Y2.5%
Sales Q2Q%-29.92%
Revenue Next Year-19.77%
Revenue Next 2Y-8.26%
Revenue Next 3Y-2.79%
Revenue Next 5YN/A
EBIT growth 1Y-252.29%
EBIT growth 3Y-16.63%
EBIT growth 5Y-6.96%
EBIT Next Year-117.37%
EBIT Next 3Y9.21%
EBIT Next 5YN/A
FCF growth 1Y34.57%
FCF growth 3Y43.39%
FCF growth 5Y4.49%
OCF growth 1Y45.21%
OCF growth 3Y32.35%
OCF growth 5Y1.94%